John Trizzino, EVP, CBO and CFO at NOVAVAX INC (NVAX), sold 78,576 shares at $153.95 ($11.7M) on 2020-08-18, disclosed to the SEC on 2020-08-20.
Open-market sale of $11.7M NVAX by EVP, CBO and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.85 | 776 | $111K | 0.9% |
| 2 | $142.85 | 776 | $111K | 0.9% |
| 3 | $143.99 | 300 | $43K | 0.4% |
| 4 | $146.21 | 4,900 | $716K | 6.1% |
| 5 | $146.95 | 8,094 | $1.2M | 10.2% |
| 6 | $146.95 | 8,094 |
| $1.2M |
| 10.2% |
| 7 | $147.99 | 9,101 | $1.3M | 11.5% |
| 8 | $147.99 | 9,101 | $1.3M | 11.5% |
| 9 | $149.08 | 6,600 | $984K | 8.4% |
| 10 | $149.08 | 6,600 | $984K | 8.4% |
| 11 | $149.83 | 1,800 | $270K | 2.3% |
| 12 | $150.85 | 4,010 | $605K | 5.2% |
| 13 | $150.85 | 4,010 | $605K | 5.2% |
| 14 | $152.22 | 4,199 | $639K | 5.5% |
| 15 | $152.22 | 4,199 | $639K | 5.5% |
| 16 | $153.16 | 1,708 | $262K | 2.2% |
| 17 | $153.16 | 1,708 | $262K | 2.2% |
| 18 | $153.95 | 1,300 | $200K | 1.7% |
| 19 | $153.95 | 1,300 | $200K | 1.7% |
| Total | $148.94 avg | 78,576 | $11.7M | 100% |
| Filing → |
| NVAX | SELL | 2021-09-22 | $6.8M | — | Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |